On June 23, Eli Lilly and Company (NYSE:LLY) declared a quarterly dividend of $1.50 per share, which was in line with its ...

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

Eli Lilly and Company (NYSE: LLY) is one of the best long term low volatility stocks to buy now. In a report released on July ...

Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...

Eli Lilly (LLY ... Over the last four quarters, Lilly surpassed consensus EPS estimates two times. The company topped consensus revenue estimates three times over this period. No investment decision ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

In the latest quarter, 7 analysts provided ratings for Eli Lilly LLY +1.30% Get Free Report , showcasing a mix of bullish and ...

In 2022, over 1 billion people were affected by obesity, driving innovation in therapeutic advancements. Emerging treatments focus on appetite control and metabolic pathways, with pharmaceutical ...

While Eli Lilly has struggled in the past year due to competitive pressures, the statistical winds may finally favor LLY ...

I recommend buying Eli Lilly and Company stock after strong Q2 earnings, with technical indicators pointing to upward momentum. Click for more on LLY stock.

Eli Lilly’s robust pipeline is a key factor in its bull case. The company has several promising candidates in late-stage development that could become significant growth drivers.

INDIANAPOLIS and WEST LAFAYETTE, May 9, 2025 — Eli Lilly and Company (NYSE: LLY) and Purdue University announced Friday (May 9) a significant expansion of their long-standing alliance, with Lilly’s ...